The burden of disease for treatment-resistant depression.
about
Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trialEpigenetic effect of chronic stress on dopamine signaling and depressionMindfulness-based cognitive therapy (MBCT) versus the health-enhancement program (HEP) for adults with treatment-resistant depression: a randomized control trial study protocol.A Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy for Treatment-Resistant Depression.Depression and immunity: a role for T cells?Randomised controlled trial of the clinical and cost effectiveness of a specialist team for managing refractory unipolar depressive disorder.Antidepressant Use in Chronic Pain Management: Is There Evidence of a Role for Duloxetine?Association of subsyndromal and depressive symptoms with inflammatory markers among different ethnic groups: the multi-ethnic study of atherosclerosis (MESA).Diagnosis and management of depression in primary care: a clinical update and review.Efficacy and safety of olanzapine/fluoxetine combination vs fluoxetine monotherapy following successful combination therapy of treatment-resistant major depressive disorder.Mortality and suicide risk in treatment-resistant depression: an observational study of the long-term impact of intervention.Striatal dopamine D2/3 receptor availability in treatment resistant depressionElevated level of DNA damage and impaired repair of oxidative DNA damage in patients with recurrent depressive disorder.Decreased Resting-State Connectivity between Neurocognitive Networks in Treatment Resistant Depression.Disturbance of the glutamatergic system in mood disorders.Baseline brain metabolism in resistant depression and response to transcranial magnetic stimulation.The inflammasome: pathways linking psychological stress, depression, and systemic illnessesA role of Yueju in fast-onset antidepressant action on major depressive disorder and serum BDNF expression: a randomly double-blind, fluoxetine-adjunct, placebo-controlled, pilot clinical studyImproved Antidepressant Remission in Major Depression via a Pharmacokinetic Pathway Polygene Pharmacogenetic Report.A potential role for the acid-sensing T cell death associated gene-8 (TDAG8) receptor in depression-like behavior.Translating Science Into Service: Lessons Learned From the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study.Pragmatic randomized controlled trial of long-term psychoanalytic psychotherapy for treatment-resistant depression: the Tavistock Adult Depression Study (TADS)The ethics of research on deep brain stimulation for depression: decisional capacity and therapeutic misconception.Causes of Death in Adults with Mitochondrial DiseaseA review of quetiapine in combination with antidepressant therapy in patients with depression.Major depressive disorder and suicidal behavior among urban dwelling Ethiopian adult outpatients at a general hospital.The interactive effects of ketamine and magnesium upon depressive-like pathology.Olanzapine and fluoxetine combination therapy for treatment-resistant depression: review of efficacy, safety, and study design issues.Depression, stress, and anhedonia: toward a synthesis and integrated model.Approaches to understanding and addressing treatment-resistant depression: a scoping reviewSocial Network Factors as Correlates and Predictors of High Depressive Symptoms Among Black Men Who Have Sex with Men in HPTN 061.How Effective Is Algorithm-Guided Treatment for Depressed Inpatients? Results from the Randomized Controlled Multicenter German Algorithm Project 3 Trial.Significant Need for a French Network of Expert Centers Enabling a Better Characterization and Management of Treatment-Resistant Depression (Fondation FondaMental).Inter and intra-hemispheric structural imaging markers predict depression relapse after electroconvulsive therapy: a multisite study.Psychopathological and sociodemographic features in treatment-resistant unipolar depression versus bipolar depression: a comparative study.A Complex Relationship Between Suicide, Dementia, and Amyloid: A Narrative Review.Single-nucleotide polymorphisms of uracil-processing genes affect the occurrence and the onset of recurrent depressive disorder.More Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant Depression
P2860
Q26285020-4818775C-FB26-4250-9FC8-B95882ADE059Q26828593-13B26AF0-A409-4369-8F07-88735C82B503Q30360005-E34A16FB-5A8E-4210-9D1C-084FC033D467Q30383857-FDFDB97C-1003-432E-9F13-6E18BCE41CF7Q30477752-8476DBD7-9CCE-48D2-8D5F-30142EC7C973Q33757855-95E6863F-4C3F-456B-BA26-049603061A7EQ33778992-835F6AFB-1505-4CCC-8E6E-2E2D0174543DQ33838255-054CC15F-6B1C-4024-8CC8-B959DB0F331EQ34288455-3FF51AB6-1207-43B7-A0FF-CCB517BC4005Q34393030-13E79C71-687F-4FA9-826A-583371D2D522Q34469254-16EF1F25-B2D7-4C95-A668-553F42C13294Q34550088-716A74F4-8B25-4711-AB80-C238D32E4EB2Q35087647-092D8E36-7A19-4E17-81BB-F5BDE880C31DQ35135305-21925E60-D0CE-4996-95E6-34FD1D0DF651Q35149888-3FDE0566-12F4-423A-8456-3EEEF494D9A6Q35592041-39F78224-D48D-4163-83E5-CED4E3279942Q35592049-9AD7CA90-87B7-4B37-859E-6692515B7773Q35939606-4D527565-2038-4AF5-AD0A-9905048CC3D8Q35965584-E028EEA4-350F-46D6-9458-AD19A134EC85Q35988667-29F8C854-F6FF-48A1-8E53-AE22BE73D97AQ36088822-95D03A17-E4E6-4DFE-BEC9-4FE325E08101Q36118719-8BC70C6C-3E37-4B10-B72F-1FD1AD4A2976Q36761365-839B466C-8FAC-4A39-A56F-00FCB7467110Q36895282-4447A53A-9586-4957-BDAD-A5C84D8C81D9Q37129835-E409FB65-66C2-47E6-8C5A-F6FC40C372B5Q37134020-BA79B597-0833-4A9A-B4F4-4AF3227B3932Q37249086-56B5A9E8-A719-42CC-B775-91B3F32EF83AQ37252495-0A6E6E40-FFAD-49A5-BE56-22257FEF186BQ37678648-E4411866-6773-46E6-8ABC-5D412C02A5FBQ38008653-1719ABA7-4FED-4702-AA47-5886C0470FFEQ40592766-CB2DEAE9-FF92-4D7D-A5D5-5FAC3BD134C1Q41595348-C767A7A4-975F-43FD-ACCA-74043B300AE5Q47140935-03B737A0-5EB4-4151-AA3E-56FE1E943F46Q47347879-D4E3DE63-23E2-491E-A958-0CA6DE11CEE9Q53701524-12C05D56-9D49-4859-B791-22AEFCBD8964Q55129707-FE91BE22-A1D8-4944-BCB6-C88B83086FE8Q55410550-316BB076-1D15-4979-BC40-2A29DB8EBEDBQ58122738-A21BC4B2-19C7-4B21-88C1-C90DAA94F93F
P2860
The burden of disease for treatment-resistant depression.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The burden of disease for treatment-resistant depression.
@ast
The burden of disease for treatment-resistant depression.
@en
type
label
The burden of disease for treatment-resistant depression.
@ast
The burden of disease for treatment-resistant depression.
@en
prefLabel
The burden of disease for treatment-resistant depression.
@ast
The burden of disease for treatment-resistant depression.
@en
P1476
The burden of disease for treatment-resistant depression.
@en
P2093
P478
62 Suppl 16
P577
2001-01-01T00:00:00Z